OTC labeling meeting postponed
This article was originally published in The Rose Sheet
Executive Summary
FDA/industry working group meeting scheduled for Nov. 1 postponed due to late submission of supporting docuemtns. Due to other commitments, FDA "personnel will not permit a shortened review time of the materials," the agency said. The first available date to reschedule the OTC labeling meeting is Nov. 23 from 10 a.m. to 12 p.m. Once FDA receives the supporting materials, it will outline an agenda